drugset / Trial / NCT04594226

Electroacupuncture Therapy for Treating Postherpetic Neuralgia

NCT04594226

RandomizedParallel-groupSingle-blindTreatment

Summary

Postherpetic neuralgia (PHN) has a high incidence rate and severely impact on quality of life and health care costs, interfering with physical, emotional and social functioning of affected patients. Current therapeutic options for PHN mainly include analgetic and local anaesthesia for selective nerve blockade. Nevertheless, the efficacy of analgetic is always limited by inevitable side effects, in which patients have poor compliance. Moreover, for some most suffering patients, the control of pain is often unsatisfactory despite the administration of complex combinations. As a non-pharmarceutical therapy, acupuncture is widely use for a wide range of pain conditions. Thus, it might be an alternative treatment for PHN. The aim of this multicenter randomized controlled trial is to investigate the efficacy and safety of electroacupuncture therapy in patients with postherpetic neuralgia.

Timeline

Start
2020-11-11
Primary completion
2021-12-31
Completion
2021-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background Gabapentin Small molecule